Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Vulvar Neoplasms 1Uterine Neoplasms 1Sentinel Lymph Node 1Rectal Neoplasms 1Node-positive Breast Cancer 1Neoplasm Micrometastasis 1Lymphatic Metastasis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × Sentinel Lymph Node Biopsy × Clear all
NCT01097265 2013-08-12

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Unknown
1,500 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡